risks of glp 1 agonists The promise and peril GLP-1 agonists: What we do (and don't) know as of August 2024 Effects of GLP-1 Agonists on
Description
CA, congenital anomaly

As mentioned, GLP-1RAs can reduce the content of systemic inflammation markers

Manitpisitkul, P

This marker is sort of a broad marker of systemic inflammation